Maricann Group to Enter Phase 1 Build Out of 942,000 sq. ft. Cultivation Facility

Maricann Group Inc. (CSE:MARI) (OTCQB:MRRCF) announced that the company has received an occupancy permit for its Phase One facility in Langton, Ontario.

Maricann Group is now ready to begin cultivation in its Canadian which is now awaiting approval from Health Canada. Phase One is expected to increase the Company’s annual growing capacity to 25,000 kg of dry cannabis flower per year. Phase One is only the first of 217,000 square feet that will eventually grow into a planned 942,000 square foot facility.

About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario, Canada where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada, and Dresden, Saxony, Germany. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, capable of producing 95,000 kg of dry cannabis flower per year to support existing and future patient growth.

For more information about Maricann, please visit our website at